PATH developed this fact sheet in response to questions about the recommended reinjection time frames for subcutaneous DMPA (DMPA-SC). This document summarizes the World Health Organization (WHO) recommendations for reinjection timing. The brief also explains why clients living with HIV, including those using antiretroviral therapies, can use DMPA on the same schedule as any other client.
Institutional author(s): PATH
Publication date: 2017